3-(5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one

Catalog No. :
ACFFQT827
CAS No. :
439080-96-3
Molecular Formula :
C20H20FNO4
Molecular Weight :
357.38

IUPAC Name:3-(5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one

3-(5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
IUPAC Name3-(5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
MDL No.MFCD09753566
Molecular FormulaC20H20FNO4
Molecular Weight357.38
SMILESO=C1OCC(C2=CC=CC=C2)N1C(CCCC(C3=CC=C(F)C=C3)O)=O
InChI KeyAVAZNWOHQJYCEL-UHFFFAOYSA-N
Synonym3-[5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyloxazolidin-2-one;(S)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one;3-[5-(4-FLUOROPHENYL)-5-HYDROXY-1-OXOPENTYL]-4-PHENYL-2-OXAZOLIDINONE;2-Oxazolidinone, 3-[5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-
CAS No.439080-96-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACFFQT827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACABQE812 route compound structure diagram
    ACABQE8127480-32-2 In Stock
  4. Then
  5. ACFFQT827 route product structure diagram
    ACFFQT827439080-96-3
Inquiry

2. ACFFQT827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFFQT827 route product structure diagram
    ACFFQT827439080-96-3
Inquiry

Comments (0)